Pain Management

  • Recofol
  • Sufentanil
  • Ruituoxi
  • AF102
  • Gastroenterology

  • Lactéol Fort
  • Oral Rehydration Salts
  • Nephrology

  • Phosmin
  • FC818
  • Luolinping
  • Calcitriol
  • M8
  • NKF201
  • NKF202
  • Oncology

  • 801
  • AD1
  • Consumer Health

  • Xiexinshu SR
  • High-C
  • C+
  • Recofol®

    Product: Recofol® (propofol) injection

    Induction and maintenance of general anesthesia (Rx)
    Sedation during intensive care (Rx)
    Sedation during surgical and diagnostic procedures with local anesthesia (Rx)

    Status: Marketed

    RecofolLicensed from Bayer Schering Pharma, Recofol® was the first of the new class of intravenous anesthetic agents – the alkylphenols – to be commercially introduced in China. It is a sedative-hynoptic agent with rapid onset and recovery, with broad applications in general anesthesia and sedation.

    As Recofol® is not an analgesic agent, supplementation with intravenous opioids such as fentanyl or sufentanil is required.

    Download Recofol Brochure

    Download Recofol Package Insert

        PUMC Pharmaceutical Co., Ltd.